14
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      PERK-Mediated Unfolded Protein Response Activation and Oxidative Stress in PARK20 Fibroblasts

      research-article

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          PARK20, an early onset autosomal recessive parkinsonism is due to mutations in the phosphatidylinositol-phosphatase Synaptojanin 1 (Synj1). We have recently shown that the early endosomal compartments are profoundly altered in PARK20 fibroblasts as well as the endosomal trafficking. Here, we report that PARK20 fibroblasts also display a drastic alteration of the architecture and function of the early secretory compartments. Our results show that the exit machinery from the Endoplasmic Reticulum (ER) and the ER-to-Golgi trafficking are markedly compromised in patient cells. As a consequence, PARK20 fibroblasts accumulate large amounts of cargo proteins within the ER, leading to the induction of ER stress. Interestingly, this stressful state is coupled to the activation of the PERK/eIF2α/ATF4/CHOP pathway of the Unfolded Protein Response (UPR). In addition, PARK20 fibroblasts reveal upregulation of oxidative stress markers and total ROS production with concomitant alteration of the morphology of the mitochondrial network. Interestingly, treatment of PARK20 cells with GSK2606414 (GSK), a specific inhibitor of PERK activity, restores the level of ROS, signaling a direct correlation between ER stress and the induction of oxidative stress in the PARK20 cells. All together, these findings suggest that dysfunction of early secretory pathway might contribute to the pathogenesis of the disease.

          Related collections

          Most cited references78

          • Record: found
          • Abstract: found
          • Article: not found

          Oxidative protein folding in eukaryotes

          The endoplasmic reticulum (ER) provides an environment that is highly optimized for oxidative protein folding. Rather than relying on small molecule oxidants like glutathione, it is now clear that disulfide formation is driven by a protein relay involving Ero1, a novel conserved FAD-dependent enzyme, and protein disulfide isomerase (PDI); Ero1 is oxidized by molecular oxygen and in turn acts as a specific oxidant of PDI, which then directly oxidizes disulfide bonds in folding proteins. While providing a robust driving force for disulfide formation, the use of molecular oxygen as the terminal electron acceptor can lead to oxidative stress through the production of reactive oxygen species and oxidized glutathione. How Ero1p distinguishes between the many different PDI-related proteins and how the cell minimizes the effects of oxidative damage from Ero1 remain important open questions.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Mitochondrial dysfunction and oxidative stress in Parkinson's disease.

            Parkinson's disease (PD) is a movement disorder that is characterized by the progressive degeneration of dopaminergic neurons in substantia nigra pars compacta resulting in dopamine deficiency in the striatum. Although majority of the PD cases are sporadic several genetic mutations have also been linked to the disease thus providing new opportunities to study the pathology of the illness. Studies in humans and various animal models of PD reveal that mitochondrial dysfunction might be a defect that occurs early in PD pathogenesis and appears to be a widespread feature in both sporadic and monogenic forms of PD. The general mitochondrial abnormalities linked with the disease include mitochondrial electron transport chain impairment, alterations in mitochondrial morphology and dynamics, mitochondrial DNA mutations and anomaly in calcium homeostasis. Mitochondria are vital organelles with multiple functions and their dysfunction can lead to a decline in energy production, generation of reactive oxygen species and induction of stress-induced apoptosis. In this review, we give an outline of mitochondrial functions that are affected in the pathogenesis of sporadic and familial PD, and hence provide insights that might be valuable for focused future research to exploit possible mitochondrial targets for neuroprotective interventions in PD. Copyright © 2013 Elsevier Ltd. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Mitochondrial dysfunction in Parkinson's disease.

              Mitochondria are highly dynamic organelles which fulfill a plethora of functions. In addition to their prominent role in energy metabolism, mitochondria are intimately involved in various key cellular processes, such as the regulation of calcium homeostasis, stress response and cell death pathways. Thus, it is not surprising that an impairment of mitochondrial function results in cellular damage and is linked to aging and neurodegeneration. Many lines of evidence suggest that mitochondrial dysfunction plays a central role in the pathogenesis of Parkinson's disease (PD), starting in the early 1980s with the observation that an inhibitor of complex I of the electron transport chain can induce parkinsonism. Remarkably, recent research indicated that several PD-associated genes interface with pathways regulating mitochondrial function, morphology, and dynamics. In fact, sporadic and familial PD seem to converge at the level of mitochondrial integrity.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Neurosci
                Front Neurosci
                Front. Neurosci.
                Frontiers in Neuroscience
                Frontiers Media S.A.
                1662-4548
                1662-453X
                27 June 2019
                2019
                : 13
                : 673
                Affiliations
                [1] 1Department of Medicine, Surgery and Dentistry “Scuola Medica Salernitana”, University of Salerno , Salerno, Italy
                [2] 2Department of Pharmacy, University of Salerno , Salerno, Italy
                [3] 3Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II , Naples, Italy
                [4] 4Section of Neuroscience, Department of Medicine, Surgery and Dentistry, University of Salerno , Salerno, Italy
                [5] 5Department of Neuroscience, Reproductive, and Odontostomatological Sciences, University of Naples Federico II , Naples, Italy
                [6] 6Telethon Institute of Genetics and Medicine , Pozzuoli, Italy
                [7] 7Department of Clinical Genetics, Erasmus MC , Rotterdam, Netherlands
                Author notes

                Edited by: Victor Tapias, Weill Cornell Medicine, United States

                Reviewed by: Wensheng Lin, University of Minnesota Twin Cities, United States; Licio A. Velloso, State University of Campinas, Brazil

                *Correspondence: Simona Paladino, spaladin@ 123456unina.it

                These authors have contributed equally to this work

                Co-last authors

                This article was submitted to Neurodegeneration, a section of the journal Frontiers in Neuroscience

                Article
                10.3389/fnins.2019.00673
                6610533
                3954cea7-cb0c-4676-8698-4e33555df1e3
                Copyright © 2019 Amodio, Moltedo, Fasano, Zerillo, Oliveti, Di Pietro, Faraonio, Barone, Pellecchia, De Rosa, De Michele, Polishchuk, Polishchuk, Bonifati, Nitsch, Pierantoni, Renna, Criscuolo, Paladino and Remondelli.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 21 March 2019
                : 12 June 2019
                Page count
                Figures: 6, Tables: 0, Equations: 0, References: 96, Pages: 14, Words: 0
                Categories
                Neuroscience
                Original Research

                Neurosciences
                park20,perk (pkr-like endoplasmic reticulum kinase),oxydative stress,er stress,synaptojanin 1,membrane trafficking,mitochondrial dysfunction,parkinson’s disease

                Comments

                Comment on this article